न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

rex medical ltd - cyproterone acetate 2mg;  ;  ; ethinylestradiol 0.035mg;   - film coated tablet - active: cyproterone acetate 2mg     ethinylestradiol 0.035mg   excipient: hypromellose lactose monohydrate magnesium stearate povidone propylene glycol purified talc   quinoline yellow starch titanium dioxide colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propylene glycol purified talc   starch titanium dioxide - androgen-dependent diseases in women are an indication for treatment with ginet. these diseases may include: acne (where local treatment or oral antibiotics alone have not been successful), especially pronounced forms of acne that may be accompanied by inflammation or formation of nodes (acne nodulocystica, acne papulopustulosa), seborrhea, mild forms of hirsutism and/or androgenic alopecia. oral contraception in women requiring treatment for these androgen-dependent diseases is an indication for treatment with ginet. however ginet is not recommended in women solely for contraception. it should not be used in combination with other hormonal contraceptives. ginet is indicated for the relief of symptoms of polycystic ovary syndrome.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 20 mg/ml;  ;   - syrup - 100 mg/5ml - active: carbamazepine 20 mg/ml     excipient: caramel hyetellose macrogol stearate 400 methyl hydroxybenzoate powdered cellulose propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 20 mg/ml;   - syrup - 100 mg/5ml - active: carbamazepine 20 mg/ml   excipient: caramel hyetellose macrogol stearate 400 methyl hydroxybenzoate powdered cellulose propyl hydroxybenzoate propylene glycol purified water saccharin sodium sorbic acid sorbitol - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 200mg;  ;   - tablet - 200 mg - active: carbamazepine 200mg     excipient: carmellose sodium colloidal silicon dioxide magnesium stearate microcrystalline cellulose - · epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 400mg;   - tablet - 400 mg - active: carbamazepine 400mg   excipient: carmellose sodium colloidal silicon dioxide magnesium stearate microcrystalline cellulose - · epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 200mg;  ;   - modified release tablet - 200 mg - active: carbamazepine 200mg     excipient: carmellose sodium colloidal silicon dioxide ethylcellulose hypromellose yellow, red, white suspension iron oxide red iron oxide yellow magnesium stearate methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil purified talc   purified water titanium dioxide - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 400mg;   - modified release tablet - 400 mg - active: carbamazepine 400mg   excipient: carmellose sodium colloidal silicon dioxide ethylcellulose hypromellose yellow, red, white suspension iron oxide red iron oxide yellow magnesium stearate methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil purified talc   purified water titanium dioxide - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

इसराइल - अंग्रेज़ी - Ministry of Health

novartis israel ltd - carbamazepine - tablets - carbamazepine 200 mg - carbamazepine - carbamazepine - epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic depressive illness.

इसराइल - अंग्रेज़ी - Ministry of Health

novartis israel ltd - carbamazepine - syrup - carbamazepine 100 mg / 5 ml - carbamazepine - carbamazepine - epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic-depressive illness.

इसराइल - अंग्रेज़ी - Ministry of Health

novartis israel ltd - carbamazepine - tablets slow release - carbamazepine 400 mg - carbamazepine - carbamazepine - epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in mania depressive illness.